Key facts
- JANUS HENDERSON GROUP PLC filed SCHEDULE 13G/A for LEXEO THERAPEUTICS, INC. Common Stock (LXEO).
- Disclosed ownership: 10%.
- Date of event: 28 Nov 2025.
JANUS HENDERSON GROUP PLC - 28 Nov 2025 SCHEDULE 13G/A Report for LEXEO THERAPEUTICS, INC. Common Stock (LXEO)
- Filing manager
- JANUS HENDERSON GROUP PLC
- Reporting owner
- JANUS HENDERSON GROUP PLC
- Disclosed shares
- 7,291,434 shares
- Ownership percentage
- 10%
- Form type
- SCHEDULE 13G/A
- Filing time
- 08 Dec 2025, 11:45:30 UTC
- Event date
- 28 Nov 2025
- Previous filing
- 14 Nov 2025
- SEC filing
- View on sec.gov
Reporting parties
Subject security
Ownership signal
SEC evidence
Key filing fact
JANUS HENDERSON GROUP PLC disclosed 10% ownership in LEXEO THERAPEUTICS, INC. Common Stock (LXEO) on 28 Nov 2025.
Change
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 08 Dec 2025, 11:45.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (1)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 10% | 7,291,434 | 0 | 7,291,434 | Kristin Mariani | Head of North America Compliance, CCO |
CIK / CUSIP context first